CHA has submitted comments on the Centers for Medicare & Medicaid Services’ proposed rule updating policies for the contract year 2023 Medicare Advantage (MA) and Medicare prescription drug benefit programs.
This content is restricted to members.
CHA Comments on Medicare Advantage and Part D Plans Proposed Rule
For CEOs, CFOs, government relations executives, finance & reimbursement staff
